BioNTech Buoyant On CAR-T/CARVac Combo Data
Promising Results Presented At AACR
CAR-T has revolutionized the treatment options for blood cancers but its application for solid tumors has fallen short. The German biotech hopes that by combining a CAR-T cell therapy with an mRNA vaccine could be a gamechanger.
